LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Research output: Contribution to journal › Journal article › Research › peer-review
Lysyl oxidase-like 2 (LOXL2) is a matrix remodeling enzyme that has been shown to play a key role in invasion and metastasis of breast carcinoma cells. However, very little is known about its role in normal tissue homeostasis. Here, we investigate the effects of LOXL2 expression in normal mammary epithelial cells in order to gain insight into how LOXL2 mediates cancer progression.
Original language | English |
---|---|
Journal | Breast cancer research : BCR |
Volume | 15 |
Issue number | 4 |
Pages (from-to) | R67 |
ISSN | 1465-5411 |
DOIs | |
Publication status | Published - 23 Aug 2013 |
ID: 105329122